Update on the 2023 CCS/CAIC Guidelines for Antiplatelet Therapy - A Deeper Dive

Explore the latest updates on antiplatelet therapy guidelines in this 57-minute cardiology rounds presentation. Dive deep into the 2023 CCS/CAIC Focus Update with Dr. Derek So, a staff cardiologist, clinical investigator, and associate professor at the University of Ottawa Heart Institute. Gain insights into final recommendations, high bleeding risk considerations, and practical tips for implementation. Examine the best P2Y12 agents, de-escalation strategies, and the rationale behind them. Analyze key studies like AUGUSTUS and their implications for STEMI patients. Discuss long-term management of NSTEMI-ACS and address current controversies in the field. Engage with the International Guidelines Committee's perspective and participate in a Q&A session to enhance your understanding of antiplatelet therapy in cardiovascular care.

Introduction
Final Recommendation
High Bleeding Risk
Summary
Practical Tips
Best P212 Agent
Deescalation
Why are you deescalate
Is there good data
Practical tip
Atal prolation
Augustus study
Stemi
Notic
Longterm
CPO
ACS
Controversies
International Guidelines Committee
Questions